Autres langues Respiri Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 07:59:16 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,033 ^AUD	-5,71 %		-8,33 %	+10,00 %

18/04	Transcript : Respiri Limited - Shareholder/Analyst Call
29/02	Respiri Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
Respiri Limited Announces Executive Changes	28/01
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	25/01
Respiri Limited Appoints Tom Takubo as Non-Executive Director	13/12
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	03/11
Respiri Limited Secures Two Additional Healthcare Provider Contract	29/09/23
Australian Bourse Halts Trading in Respiri’s Securities	14/09/23
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Respiri Completes Access Manages Services Acquisition	14/08/23
Respiri Completes AU$3 Million Share Purchase Plan	08/08/23
Respiri Extends Closing Date of Share Purchase Plan	25/07/23
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	10/07/23
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23/05/23
Respiri Appoints Chief Commercial Officer for US Market	12/04/23
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	12/04/23
L'agenda di domani	27/02/23
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23
L'agenda della settimana	27/02/23
L'agenda della prossima settimana	24/02/23
Respiri Forms US Advisory Board to Advance Wheezo Program as Part of Standard of Care; Shares Slump 9%	23/02/23

Aucun résultat pour cette recherche